All posts by Simmons Hanly Conroy
By Simmons Hanly Conroy | February 6, 2015
Detoxifying Asbestos Brakes in California and Washington
More often than not, when I say that I represent people who suffer from asbestos-related cancer, the response that I get is: How can people still be getting cancer from asbestos? Hasn’t… Read More
By Simmons Hanly Conroy | January 18, 2015
Get to Know the Simmons Hanly Conroy Shareholders – Part 3
Once a month, we have been sharing some facts about each of shareholders who make up the Simmons Hanly Conroy family. Now it’s time to introduce the rest. Our goal is to… Read More
By Simmons Hanly Conroy | January 16, 2015
Mesothelioma and Women: The Truth Behind Take-Home Exposure
Many asbestos occupations like auto mechanics, construction workers and oil refinery workers were made up of predominantly male employees. For this reason, a large portion of patients who are diagnosed with mesothelioma… Read More
By Simmons Hanly Conroy | January 12, 2015
The Must-Know Facts about Blood-Thinning Medications
Blood thinning medications are used to prevent blood clots. Blood clots are health risks that increase chances of stroke, heart attack, and various other health issues. Warfarin is one of the original… Read More
By Simmons Hanly Conroy | December 31, 2014
Pharmaceutical News Wrap Up: December 2014
The pharmaceutical attorneys at Simmons Hanly Conroy understand the importance of staying up to date on the latest headlines. Below is a list of some of the most recent pharmaceutical news concerning… Read More
By Simmons Hanly Conroy | December 30, 2014
Asbestos and Mesothelioma News Wrap Up: December 2014
The mesothelioma lawyers at Simmons Hanly Conroy understand the importance of staying up to date on the latest asbestos and mesothelioma news. Below is a group of some of the most recent… Read More
By Simmons Hanly Conroy | December 18, 2014
FDA Advisers Shown to Have Questionable Financial Ties
In July 2014, an adviser on a U.S. Food and Drug Administration (FDA) gynecology panel stepped down after he was questioned about conflicts of interest. It was later discovered that this panel… Read More
By Simmons Hanly Conroy | December 17, 2014
The History of Risperdal FDA Warnings
Risperdal was approved by the U.S. Food and Drug Administration (FDA) in 1994. It is recognized as a medication used to treat psychological issues. The antipsychotic drug is approved for use in patients… Read More
By Simmons Hanly Conroy | December 17, 2014
Get to Know the Simmons Hanly Conroy Shareholders – Part 2
In October, we introduced ten members of the Simmons Hanly Conroy leadership team. Now it’s time to introduce ten more. By getting to know our shareholders, you can see for yourself the… Read More
By Simmons Hanly Conroy | December 16, 2014
Blood Thinners Like Xarelto and Pradaxa Classified as “Dangerous”: Here’s Why
Both Xarelto and Pradaxa are popular blood thinners prescribed to reduce the risk of blood clots that can cause a stroke or heart attack. These types of medications, however, come with serious… Read More
